candesartan and aspartic acid

candesartan has been researched along with aspartic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunyady, L; Kersemans, V; Le, MT; Szaszák, M; Vanderheyden, PM; Vauquelin, G1
Eguchi, K; Hoshide, S; Ishikawa, J; Ishikawa, S; Kario, K; Matsui, Y; Morinari, M; Shimada, K1

Other Studies

2 other study(ies) available for candesartan and aspartic acid

ArticleYear
Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors.
    Biochemical pharmacology, 2003, Apr-15, Volume: 65, Issue:8

    Topics: Alanine; Amino Acid Substitution; Animals; Antihypertensive Agents; Aspartic Acid; Benzimidazoles; Biphenyl Compounds; CHO Cells; Cricetinae; Humans; Imidazoles; Kinetics; Losartan; Mutagenesis, Site-Directed; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Transfection; Tritium

2003
Diabetic brain damage in hypertension: role of renin-angiotensin system.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:5

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspartic Acid; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain; Carotid Artery, Internal; Case-Control Studies; Cerebrovascular Circulation; Cerebrovascular Disorders; Diabetes Complications; Female; Hemodynamics; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Middle Cerebral Artery; Renin-Angiotensin System; Tetrazoles

2005